These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6321311)
1. Oesophageal function after oral ranitidine: an acute double blind study in normal subjects. Baldi F; Ferrarini F; Balestra R; Borioni D; Brunetti G; Barbara L Hepatogastroenterology; 1984 Feb; 31(1):38-40. PubMed ID: 6321311 [TBL] [Abstract][Full Text] [Related]
2. Double-blind crossover study of ranitidine and ebrotidine in gastro-esophageal reflux disease. Sito E; Thor PJ; M[aczka M; Lorens K; Konturek SJ; Maj A J Physiol Pharmacol; 1993 Sep; 44(3):259-72. PubMed ID: 8241527 [TBL] [Abstract][Full Text] [Related]
3. Effect of naproxen on gastroesophageal reflux and esophageal function: a randomized, double-blind, placebo-controlled study. Scheiman JM; Patel PM; Henson EK; Nostrant TT Am J Gastroenterol; 1995 May; 90(5):754-7. PubMed ID: 7733082 [TBL] [Abstract][Full Text] [Related]
4. The effect of ranitidine on oesophageal motility. Naess F; Nygaard K; Haffner J Scand J Gastroenterol; 1987 Nov; 22(9):1064-6. PubMed ID: 3321394 [TBL] [Abstract][Full Text] [Related]
5. Ranitidine, cimetidine, antacids, and gastro-oesophageal reflux: results of a 20-hour oesophageal pH study. Desechalliers JP; Galmiche JP; Touchais JY; Denis P; Colin R Int J Clin Pharmacol Res; 1984; 4(3):217-22. PubMed ID: 6092288 [TBL] [Abstract][Full Text] [Related]
6. Oral ranitidine and duration of gastric pH >4.0 in infants with persisting reflux symptoms. Salvatore S; Hauser B; Salvatoni A; Vandenplas Y Acta Paediatr; 2006 Feb; 95(2):176-81. PubMed ID: 16449023 [TBL] [Abstract][Full Text] [Related]
7. Gastro-oesophageal function in normal subjects after oral administration of ranitidine. Wallin L; Madsen T; Boesby S Gut; 1983 Feb; 24(2):154-7. PubMed ID: 6133814 [TBL] [Abstract][Full Text] [Related]
8. Relationship between the mechanism of gastro-oesophageal reflux and oesophageal acid exposure in patients with reflux disease. Scheffer RC; Wassenaar EB; Herwaarden MA; Holloway RH; Samsom M; Smout AJ; Akkermans LM Neurogastroenterol Motil; 2005 Oct; 17(5):654-62. PubMed ID: 16185303 [TBL] [Abstract][Full Text] [Related]
9. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH. Tutuian R; Mainie I; Allan R; Hargreaves K; Agrawal A; Freeman J; Gale J; Castell DO Aliment Pharmacol Ther; 2006 Jul; 24(1):155-62. PubMed ID: 16803614 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry. Weihrauch TR; Förster CF; Krieglstein J Postgrad Med J; 1979; 55 Suppl 1():7-10. PubMed ID: 382158 [TBL] [Abstract][Full Text] [Related]
11. [Single dose treatment with H2-receptor-antagonists: is bedtime administration too late?]. Fritsch WP Z Gastroenterol; 1987 Dec; 25(12):788-9. PubMed ID: 3326310 [No Abstract] [Full Text] [Related]
12. Gastroesophageal reflux induced by white wine: the role of acid clearance and "rereflux". Pehl C; Frommherz M; Wendl B; Pfeiffer A Am J Gastroenterol; 2002 Mar; 97(3):561-7. PubMed ID: 11922547 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of esophageal manometry and gastroesophageal pH monitoring for responsiveness of reflux disease to medical therapy in children. Cucchiara S; Campanozzi A; Greco L; Franco MT; Emiliano M; Alfieri E; Calabrese F; Numeroso V Am J Gastroenterol; 1996 Apr; 91(4):680-5. PubMed ID: 8677928 [TBL] [Abstract][Full Text] [Related]
14. A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn. Rodriguez-Stanley S; Ciociola AA; Zubaidi S; Proskin HM; Miner PB Aliment Pharmacol Ther; 2004 Nov; 20(9):975-82. PubMed ID: 15521845 [TBL] [Abstract][Full Text] [Related]
15. Different effects of an oral anticholinergic drug on gastroesophageal reflux in upright and supine position in normal, ambulant subjects: a pilot study. Koerselman J; Pursnani KG; Peghini P; Mohiuddin MA; Katzka D; Akkermans LM; Castell DO Am J Gastroenterol; 1999 Apr; 94(4):925-30. PubMed ID: 10201458 [TBL] [Abstract][Full Text] [Related]
16. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease. Cucchiara S; Staiano A; Boccieri A; De Stefano M; Capozzi C; Manzi G; Camerlingo F; Paone FM Gut; 1990 Jan; 31(1):21-5. PubMed ID: 2180792 [TBL] [Abstract][Full Text] [Related]
17. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors. Gerson LB; Boparai V; Ullah N; Triadafilopoulos G Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912 [TBL] [Abstract][Full Text] [Related]
18. The effect of parietal cell vagotomy on gastrooesophageal function in duodenal ulcer patients. Wallin L Scand J Gastroenterol; 1981; 16(1):97-102. PubMed ID: 7233084 [TBL] [Abstract][Full Text] [Related]
19. Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study. Grossi L; Spezzaferro M; Sacco LF; Marzio L Neurogastroenterol Motil; 2008 Jul; 20(7):760-6. PubMed ID: 18373654 [TBL] [Abstract][Full Text] [Related]
20. The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease. Ruth M; Finizia C; Cange L; Lundell L Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1115-21. PubMed ID: 14501621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]